Acadian Asset Management »

Lyell Immunopharma shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $184k 11k 16.15
2025-06-30 $241k 27k 8.81

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Mastercard Incorporated Cl A (MA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Booking Holdings (BKNG)
JPMorgan Chase & Co. (JPM)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Logitech Intl S A SHS (LOGI)
Broadcom Ord Shs (AVGO)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma